| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70756-810-30 | 70756-810 | HUMAN PRESCRIPTION DRUG | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | TABLET | ORAL | 20200501 | N/A | ANDA | ANDA207135 | Lifestar Pharma LLC | OLMESARTAN MEDOXOMIL | 40 mg/1 | 30 TABLET in 1 BOTTLE (70756-810-30) |
| 70756-810-90 | 70756-810 | HUMAN PRESCRIPTION DRUG | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | TABLET | ORAL | 20200501 | N/A | ANDA | ANDA207135 | Lifestar Pharma LLC | OLMESARTAN MEDOXOMIL | 40 mg/1 | 90 TABLET in 1 BOTTLE (70756-810-90) |
| 70756-809-30 | 70756-809 | HUMAN PRESCRIPTION DRUG | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | TABLET | ORAL | 20200501 | N/A | ANDA | ANDA207135 | Lifestar Pharma LLC | OLMESARTAN MEDOXOMIL | 20 mg/1 | 30 TABLET in 1 BOTTLE (70756-809-30) |
| 70756-809-90 | 70756-809 | HUMAN PRESCRIPTION DRUG | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | TABLET | ORAL | 20200501 | N/A | ANDA | ANDA207135 | Lifestar Pharma LLC | OLMESARTAN MEDOXOMIL | 20 mg/1 | 90 TABLET in 1 BOTTLE (70756-809-90) |
| 70756-808-30 | 70756-808 | HUMAN PRESCRIPTION DRUG | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | TABLET | ORAL | 20200501 | N/A | ANDA | ANDA207135 | Lifestar Pharma LLC | OLMESARTAN MEDOXOMIL | 5 mg/1 | 30 TABLET in 1 BOTTLE (70756-808-30) |
| 70756-808-90 | 70756-808 | HUMAN PRESCRIPTION DRUG | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | TABLET | ORAL | 20200501 | N/A | ANDA | ANDA207135 | Lifestar Pharma LLC | OLMESARTAN MEDOXOMIL | 5 mg/1 | 90 TABLET in 1 BOTTLE (70756-808-90) |